Weidong An
Impact in
-
- RNA modifications and cancer
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
- Receptor Mechanisms and Signaling
- Cancer-related gene regulation
Papers in
-
- RNA and protein synthesis mechanisms 4
- RNA modifications and cancer 4
- RNA Research and Splicing 4
- Metabolism, Diabetes, and Cancer 2
- Receptor Mechanisms and Signaling 2
- Surgery 2
- Pancreatic function and diabetes 2
- Co-authors
- Keqiong Ye (4 shared papers)Xing Zhu (2 shared papers)Qi Sun (2 shared papers)Yifei Du (2 shared papers)Pengfei Lan (1 shared paper)Sanduo Zheng (1 shared paper)Cheng Zhang (1 shared paper)Xining Chen (1 shared paper)
- Journals
- Nature Communications (2 papers)Science (1 paper)Stem Cells and Development (1 paper)Nature (1 paper)Molecular Cell (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Weidong An
9 papers receiving 252 citations
Peers
Comparison fields: 5 of 55
- Molecular Biology 221
- Structural Biology 3
- Aging 3
- Cellular and Molecular Neuroscience 19
- Nuclear and High Energy Physics 11
Countries citing papers authored by Weidong An
This map shows the geographic impact of Weidong An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weidong An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weidong An more than expected).
Fields of papers citing papers by Weidong An
This network shows the impact of papers produced by Weidong An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weidong An. The network helps show where Weidong An may publish in the future.
Co-authors
The 25 scholars most cited alongside Weidong An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 121 | |
| 2 | 2020 | 59 | |
| 3 | 2021 | 25 | |
| 4 | 2024 | 17 | |
| 5 | 2020 | 11 | |
| 6 | 2018 | 8 | |
| 7 | 2014 | 6 | |
| 8 | 2022 | 4 | |
| 9 | 2024 | 2 | |
| 10 | 2025 | 0 | |
| 11 | 2025 | 0 |
About Weidong An
Weidong An is a scholar working on Molecular Biology, Surgery, Cellular and Molecular Neuroscience, Finance and Clinical Biochemistry, having authored 11 papers that have together received 253 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (4 papers), RNA modifications and cancer (4 papers), RNA Research and Splicing (4 papers), Pancreatic function and diabetes (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Receptor Mechanisms and Signaling (2 papers), Metabolism and Genetic Disorders (1 paper) and Financial Markets and Investment Strategies (1 paper). The work is most often cited by research in Molecular Biology (221 citations), Structural Biology (3 citations), Aging (3 citations), Cellular and Molecular Neuroscience (19 citations) and Nuclear and High Energy Physics (11 citations). Weidong An has collaborated with scholars based in China and United States. Frequent co-authors include Keqiong Ye, Xing Zhu, Qi Sun, Yifei Du, Pengfei Lan, Sanduo Zheng, Cheng Zhang, Xining Chen, Meng‐Qiu Dong and Dan Tan. Their work appears in journals such as Nature Communications, Science, Stem Cells and Development, Nature and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.